192 related articles for article (PubMed ID: 4762437)
1. Comparative studies on the chemical stability and therapeutic effectiveness of water-insoluble 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) and its water-soluble hydrochloride against L1210 mouse leukemia.
Woodman RJ; Kline I; Field RB; Gang M
Cancer Chemother Rep; 1973; 57(4):383-91. PubMed ID: 4762437
[No Abstract] [Full Text] [Related]
2. 5-[3-(2-Chloroethyl)-1-triazenyl] imidazole-4-carboxamide and a possible mechanism of action of 5-[3, 3-bis(2-chloroethyl)-1-triazenyl] imidazole-4-carboxamide.
Shealy YF; O'Dell CA; Krauth CA
J Pharm Sci; 1975 Jan; 64(1):177-80. PubMed ID: 1169314
[No Abstract] [Full Text] [Related]
3. Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
Kline I; Woodman RJ; Gang M; Cysyk RL; Venditti JM
Cancer Chemother Rep; 1973; 57(3):291-8. PubMed ID: 4751255
[No Abstract] [Full Text] [Related]
4. Effectiveness of antileukemic agents in mice inoculated with leukemia L1210 variants resistant to 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) or 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196).
Kline I; Woodman RJ; Gang M; Venditti JM
Cancer Chemother Rep; 1971 Feb; 55(1):9-28. PubMed ID: 5121657
[No Abstract] [Full Text] [Related]
5. 5-[3,3-Bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in the treatment of childhood malignancy.
Komp DM; Land VJ; Nitschke R; Cangir A; Dyment P
Cancer Chemother Rep; 1975; 59(2 Pt 1):371-6. PubMed ID: 1097094
[No Abstract] [Full Text] [Related]
6. Imidazole carboxamides: relationship of lipophilicity to activity against intracerebral murine glioma 26 and preliminary phase II clinical trial of 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in primary and secondary brain tumors.
Levin VA; Crafts D; Wilson CB; Kabra P; Hansch C; Boldrey E; Enot J; Neely M
Cancer Chemother Rep; 1975; 59(2 Pt 1):327-31. PubMed ID: 1149010
[No Abstract] [Full Text] [Related]
7. Phase II study of 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in advanced gastrointestinal cancer.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Chemother Rep; 1972 Apr; 56(2):267-9. PubMed ID: 5043230
[No Abstract] [Full Text] [Related]
8. Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea.
Costanza ME; Nathanson L; Lenhard R; Wolter J; Colsky J; Oberfield RA; Schilling A
Cancer; 1972 Dec; 30(6):1457-61. PubMed ID: 4641757
[No Abstract] [Full Text] [Related]
9. Effectiveness of antileukemic agents in mice inoculated with a leukemia L1210 variant resistant to 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196).
Tyrer DD; Kline I; Gang M; Goldin A; Venditti JM
Cancer Chemother Rep; 1969 Sep; 53(4):229-41. PubMed ID: 5384463
[No Abstract] [Full Text] [Related]
10. 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children.
Finklestein JZ; Albo V; Ertel I; Karon M; Hammond D
Cancer Chemother Rep; 1972 Aug; 56(4):523-6. PubMed ID: 4507686
[No Abstract] [Full Text] [Related]
11. Influence of treatment schedules and route of administration on the chemotherapy of murine leukemia L1210 with 5(or 4)-[3,3-bis( 2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196).
Hoffman G; Kline I; Gang M; Tyrer DD; Venditti JM; Goldin A
Cancer Chemother Rep; 1968 Dec; 52(7):715-24. PubMed ID: 5743709
[No Abstract] [Full Text] [Related]
12. Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.
Gerner RE; Moore GE
Cancer Chemother Rep; 1973 Feb; 57(1):83-4. PubMed ID: 4704107
[No Abstract] [Full Text] [Related]
13. Evaluation of 4-carbethoxy-5(3,3-dimethyl-1-triazeno)-2-phenylimidazole (NSC-166721) and 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole (NSC-166722) as potential antitumor agents.
Heyes J; Catherall EJ; Cockburn A
Cancer Chemother Rep; 1973; 57(3):263-8. PubMed ID: 4751253
[No Abstract] [Full Text] [Related]
14. Combination chemotherapy with CCNU (NSC-79037) and 5-(3, 3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196).
Chang H; Freireich EJ; Khaliq A; Einhorn L; Gottlieb JA
Cancer Chemother Rep; 1975; 59(4):769-71. PubMed ID: 1100230
[No Abstract] [Full Text] [Related]
15. Activity of 17 beta-hydroxy-3-aza-A-homo-4 alpha-androsten-4-one-p-N, N-bis(2-chloroethyl)aminophenoxyacetate (NSC-620480) in P388 leukemia. Activity of steroidal lactams in Ehrlich tumor.
Catsoulacos P; Pairas G
Methods Find Exp Clin Pharmacol; 1990 Sep; 12(7):501-5. PubMed ID: 2087151
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy: some concepts and results.
Skipper HE
Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
[No Abstract] [Full Text] [Related]
17. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.
Frei E; Luce JK; Talley RW; Vaitkevicius VK; Wilson HE
Cancer Chemother Rep; 1972 Oct; 56(5):667-70. PubMed ID: 4569060
[No Abstract] [Full Text] [Related]
18. Complete inhibition of mouse leukaemia L1210 by 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196).
Shealy YF; Krauth CA
Nature; 1966 Apr; 210(5032):208-9. PubMed ID: 5963361
[No Abstract] [Full Text] [Related]
19. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer.
Falkson G; van Eden EB; Falkson HC
Cancer; 1974 May; 33(5):1207-9. PubMed ID: 4595974
[No Abstract] [Full Text] [Related]
20. Clinical trials with 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) given intravenously.
Bagley CM; Canellos GP; Young RC; Gallelli JF; Devita VT
Cancer Chemother Rep; 1972 Jun; 56(3):387-91. PubMed ID: 19051499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
